Approval for device modifications to the angio-seal vip vascular closure device including utilizing an automated collagen compaction mechanism for ease of use.  The device, as modified, will be marketed under the trade name angio-seal evolution vascular closure device and is indicated for use in closing and in reducing time to hemostasis at the femoral arterial puncture site in patients who have undergone diagnostic angiography or percutaneous transluminal coronary angioplasty (ptca) procedures using an 8 french or smaller procedural sheath.